戻る Agenda
[S46] Establishing Real-World-Evidence in Japan, from the Perspective of Database Utilization
Session Chair(s)
Koji Kawakami, MD, PHD
Professor and Chair, Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Japan
Real-world-evidence(RWE) has become more important, in association with increasing recognition of value-based-medicine or healthcare. In Japan, the healthcare industry, government and academia are making great efforts to establish various databases or patient registries to be utilized for clinical development, pharmacovigilance or research purpose. However, RWE in Japan is still very much behind compared with those of western countries. The purpose of this session is to discuss how to promote RWE generation in Japan, especially from the perspective of utilization of database. The overviews of RWE in Japan or other countries will be provided. Also, the speaker from Japanese pharmaceutical industry will share recent experience of RWE generation.
Speaker(s)
Koji Kawakami, MD, PHD
Professor and Chair, Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Japan
The Largest Clinical RWD Database Development in Japan - Overview and Future Opportunities
Eiko Shimizu, PHD, MSC
Project Lecturer, Pharmaco-Business Innovation, Graduate School of Phama Science, The University of Tokyo, Japan
RWD frontline: Expectation for RWD and its limitation in Japan
Toshinaga Tsuji, PHD
Scientific Leader (CNS), Medical Affairs, Shionogi & Co., Ltd, Japan
Work Productivity and Disease Burden in Patients with Pain Using Japanese Web Survey
Nancy Dreyer, MPH, FISPE
Founder, Dreyer Strategies LLC, United States
Growing Regulatory Use of RWE Outside of Japan